CMB International Capital Corporation Limited sold 1.22 million shares of BIOCYTOGEN-B (02315) stock at an average of HKD 62.2724 per share on September 8, 2026, involving about HKD 76.03 million.
Prior to the disposal, CMB International Capital Corporation Limited's long position in BIOCYTOGEN-B was 10.98 million shares, representing 9.91%; following the disposal, the holding changed to 9.76 million shares, with the long position ratio falling to 8.81%.